ProQR’s retinitis pigmentosa treatment receives fast track designation

September 9, 2019
The FDA has granted fast track designation to QR-1123, an investigational antisense oligonucleotide, ProQR Therapeutics announced in a press release…

Santen microshunt study results lead news of the week

September 7, 2019
Here are some of the past week’s top stories on

Meeting News

Ocular manifestations often present first in multiple sclerosis

September 6, 2019
COEUR D’ALENE, Idaho — There is a high frequency of ocular manifestations in patients with multiple sclerosis, both at onset and during…

Regenxbio, Clearside enter option and license agreement for SCS Microinjector

September 6, 2019
Regenxbio and Clearside Biomedical announced an option and license agreement that will give Regenxbio exclusive worldwide rights to Clearside’s…

Meeting News

OpRegen appears well tolerated in dry AMD

September 5, 2019
COEUR D’ALENE, Idaho — In patients with dry age-related macular degeneration, the implantation of human embryonic stem cell-derived…

NHS England to fund Luxturna treatment

September 5, 2019
NHS England will fund Luxturna gene therapy treatment for inherited retinal dystrophies starting in January 2020, according to a press release…

AmEx recalls all lots of bevacizumab

September 4, 2019
All lots of bevacizumab 1.25 mg/0.05 mL 31-gauge injectable and bevacizumab 2.5 mg/0.1 mL Normject TB injectable from Pacifico National, doing…

FDA urges recall of AmEx Pharmacy sterile products

August 28, 2019
Products intended to be sterile made by Pacifico National Inc., doing business as AmEx Pharmacy, should not be used due to quality and sterility…

What's Your Diagnosis?

Woman presents with unilateral blurred vision

Primary Care Optometry News, August 2019
Joanna Yee, OD; Paula Johns, OD, MPH, FAAO
A 71-year-old Native American female presented with a chief complaint of constant blurred vision at distance and near in the right eye, which began 2…

Diagnose AMD earlier with dark adaptation testing

Primary Care Optometry News, August 2019
Glenn S. Corbin, OD
An immediate referral to a retina specialist due to a bleed is a tense circumstance for all involved. However, I have learned through experience that…

In the JournalsPerspective

No improvement found in pediatric ocular injury rates in 25 years

August 26, 2019
No improvements were observed in the severity or incidence of pediatric ocular injury rates in the past 25 years, according to the U.K. Paediatric…

Career inequality for women in ophthalmic research tops news of the week

August 25, 2019
Here are some of the top stories on from the past week:

In the Journals

Wet AMD gene therapy well tolerated through 3 years

August 23, 2019
Patients with wet age-related macular degeneration who responded well to rAAV.sFLT-1 subretinal gene therapy at 1 year maintained that response…

ONL raises $3 million in financing to advance Fas inhibitor study

August 23, 2019
ONL Therapeutics will begin a first-in-human study of its Fas inhibitor for retinal diseases following the completion of $3 million in convertible…

Iconic, Novartis sign ophthalmology option agreement

August 23, 2019
Iconic Therapeutics has signed an agreement with Novartis that will give Novartis an option on Iconic’s ophthalmology program, according to a…

In the JournalsPerspective

Vehicle pollution may increase AMD risk

August 22, 2019
High rates of exposure to traffic-related air pollution may increase the risk for age-related macular degeneration. Nearly 40,000 Taiwanese residents…

Mixed phase 2a results reported for Oxurion’s anti-PlGF combined with anti-VEGF

August 22, 2019
THR-317, a humanized antibody against placental growth factor, combined with ranibizumab showed no improvement in mean best corrected visual acuity…

Graybug Vision completes Series C financing

August 21, 2019
Graybug Vision has closed $80 million in Series C financing, which will be used to advance its pan-VEGF inhibitor GB-102 into phase 2 studies and its…

Aerie begins trial of sustained release drug for retinal disease

August 20, 2019
Aerie Pharmaceuticals has initiated a clinical trial of AR-13503, a sustained release implant, for treatment of neovascular age-related macular…

Meeting NewsVideo

VIDEO: Analytical data may help predict, prevent vision loss

August 19, 2019
CHICAGO — At the American Society of Retina Specialists meeting, Daniela Ferrara, MD, MSc, PhD, discusses the use of advanced analytics in the…